Q2 2025 Management View CEO Luc Seraphin stated that Rambus "delivered a very strong second quarter, exceeding expectations for both revenue and earnings, while continuing momentum in our growth ...

Discover Kforce's Q2 2025 results: sequential revenue growth, AI-driven strategies, and consulting-led solutions amid market uncertainty.

Key Points - Adjusted earnings per share (Non-GAAP) reached $1.37 for Q2 2025, This figure beat analyst estimates by 13.25%. Revenue (GAAP) rose to $173.4 million in Q2 2025, Non-GAAP EPS exceeded ...

Analysts urge investors not to overlook Remittix but instead stack its tokens. With RTX’s working products and global use ...

Key Points - Aerospace segment drove strong growth, with sales up 15.2% (GAAP) in Q3 FY2025 and margin expanding to 21.1%. Free cash flow (non-GAAP) fell 27.8% year over year, - Management raised ...

Q2 2025 Management View Clarence L. Granger, Chairman and Interim CEO, stated that the company is maintaining focus on new ...

Tesla and the broader U.S. EV market face a critical turning point as federal incentives vanish, sales decline, and global ...

Cryptocurrency markets are heating up as Q3 rolls on, but investors are seeking beyond mainstream titans like XRP and Cardano ...

Woodward Inc. (Nasdaq: WWD), a Fort Collins-based company that designs, manufactures and services energy-conversion and control solutions for the aerospace and industrial equipment markets, reported ...

A new experiential retailer is set to transform three floors of a historic Times Square building, offering a blend of cutting-edge technology and immersive storytelling.

Discover insights into Starbucks' Q3 earnings expectations. Analysts foresee challenges in same-store sales, China margins, ...

The JAK-inhibitor will be available to veterinarians and itchy dog owners in the United Kingdom by the end of Q3 2025.